Another manufacturer has issued recalls for Irbesartan after the frequently prescribed blood-pressure medication tested positive for a probable human carcinogen. A detailed article examining the latest in a series of recalls is available here. According to the United States Food and Drug Administration (FDA), a pharmaceutical manufacturer has recalled multiple lots of Irbesartan. These drugs,…

Drug manufacturer Camber Pharmaceuticals has issued a recall for large quantities of Losartan. An article on this emerging story is available here. Currently, no patients have reported any adverse effects related to potential contamination. Patients are advised to speak with a qualified physician before discontinuing the drug. The National Drug Code (NDC) numbers associated with…

The Food and Drug Administration (FDA) announced on Tuesday, 7/26 that they are revising their boxed warning labels on packages of a class of antibacterial drugs known as fluoroquinolones. The FDA’s boxed warning labels, commonly referred to as “black box” warnings, alert doctors and patients that certain types of drugs or medical devices may pose…